Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment
Yamin Shu, Lei Wang, Yiling Ding, Qilin Zhang
Topics & Concepts
MedicineAdverse Event Reporting SystemAdverse effectPharmacovigilanceInternal medicineCommon Terminology Criteria for Adverse EventsMedDRAAdvanced Breast Cancer TherapiesMisinformation and Its ImpactsPharmacovigilance and Adverse Drug Reactions